Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

[Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].

Fukasawa, Chisa; Ooishi, Saori; Kumagai, Takuma; Koshiisi, Megumi; Sueki, Yuki; Nakajima, Kei; Mitsumori, Toru; Yoshida, Yoko; Kato, Hideki; Nangaku, Masaomi; Miyata, Toshiyuki; Kirito, Keita.
Rinsho Ketsueki; 59(2): 182-186, 2018.
Artigo em Japonês | MEDLINE | ID: mdl-29515071
Herein, we present an elderly onset case of aHUS successfully treated with eculizumab. An 80-year-old woman with severe anemia, thrombocytopenia, and acute renal dysfunction was admitted to our hospital. A laboratory test revealed steep elevation in the LDH level, and the peripheral blood smear showed erythrocyte fragmentations. Accordingly, we diagnosed thrombotic microangiopathy, and treatment with plasma exchange was immediately initiated. In addition, she required hemodialysis because of rapid impairment of the renal function. After excluding Shiga toxin-producing Escherichia coli infection and malignancy and confirming her ADMTS13 activity above 10%, we diagnosed aHUS, according to the Japanese diagnostic criteria for aHUS. Next, we initiated treatment with eculizumab. Her hematological findings improved 23 days after the starting of eculizumab. In addition, her renal function gradually recovered, and hemodialysis was discontinued. The genetic test for several complement regulatory genes tested negative. The onset of aHUS is reported in children or young adults and is rarely reported in elderly. However, our case suggests the importance of precisely diagnosing aHUS and initiating early administration of eculizumab for improving the outcome even in elderly patients.
Selo DaSilva